HST Global, Inc. Share Price Other OTC
Equities
HSTC
US40432E2028
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 3.19M 266M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net Debt 2022 | 75.89K 6.33M | Net Debt 2023 | 96.79K 8.07M | EV / Sales 2023 | - |
P/E ratio 2022 |
-4.34
x | P/E ratio 2023 |
-21.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 37.71% |
Managers | Title | Age | Since |
---|---|---|---|
Ron Howell
CEO | Chief Executive Officer | 75 | 08/08/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ron Howell
CEO | Chief Executive Officer | 75 | 08/08/08 |
1st Jan change | Capi. | |
---|---|---|
+0.75% | 42.86B | |
+11.29% | 42.74B | |
+44.47% | 41.36B | |
-8.83% | 27.68B | |
+7.52% | 25.15B | |
-23.40% | 18.63B | |
+30.66% | 12.37B | |
-2.15% | 11.92B | |
+6.85% | 11.21B |